← Back to Search
Other
Ischemic Preconditioning Claudication Study
Milwaukee, WI
N/A
Waitlist Available
Research Sponsored by Medical College of Wisconsin
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Summary
This trial found that IPC may improve walking distance in people with intermittent claudication.
Eligible Conditions
- Peripheral Arterial Disease
- Intermittent Claudication
- Vascular Ischemia
- Peripheral Vascular Disease
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 2 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Peak walking time
Secondary study objectives
Claudication onset time
Muscle Fatigue
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Ischemic PreconditioningExperimental Treatment1 Intervention
A standard blood pressure cuff will be placed on the right or left thigh, depending on the affected side, to occlude blood flow. The cuff will be inflated to 225 mmHg to prevent blood flow. Each session will consist of 4 cycles of 5 minute IPC applications, followed by 5 minutes of reperfusion for a total of 35 minutes.
Group II: ControlPlacebo Group1 Intervention
The sham intervention protocol will be identical to the IPC protocol except blood flow to the affected leg is unchanged as cuff pressure will be raised to between the venous and diastolic pressures
Find a Location
Closest Location:Froedtert and the Medical College of Wisconsin· Milwaukee, WI
Who is running the clinical trial?
Medical College of WisconsinLead Sponsor
640 Previous Clinical Trials
1,179,622 Total Patients Enrolled
4 Trials studying Peripheral Arterial Disease
146 Patients Enrolled for Peripheral Arterial Disease